Literature DB >> 30637577

Factors associated with an adverse work outcome in breast cancer survivors 5-10 years after diagnosis: a cross-sectional study.

Sietske J Tamminga1, Pieter Coenen2, Carmen Paalman3,4, Angela G E M de Boer1, Neil K Aaronson3, Hester S A Oldenburg5, Flora E van Leeuwen3, Allard J van der Beek2, Saskia F A Duijts2,3,6, Michael Schaapveld7,8.   

Abstract

PURPOSE: To identify which factors are associated with adverse work outcome 5-10 years after diagnosis.
METHODS: In this cross-sectional study, breast cancer survivors, treated between 2003 and 2008, completed a questionnaire 5-10 years after diagnosis. Adverse work outcome was defined as not having paid employment or working > 20% less compared to prediagnosis. Logistic regression analyses were conducted.
RESULTS: Of 906 participants, 326 (36%) had an adverse work outcome. In multivariable analyses, the probability of an adverse work outcome increased with age (OR, 1.03; 95% CI, 1.00-1.07), time since diagnosis (OR, 1.19; 95% CI, 1.03-1.37), and was higher among women who stated that work had become less important (OR, 2.99; 95% CI, 1.94-4.62). Factors associated with a lower probability of an adverse work outcome were having sufficient financial resources (OR, 0.23; 95% CI, 0.08-0.66), higher total work ability (OR, 0.61; 95% CI, 0.54-0.69), feeling supported at work (OR, 0.52; 95% CI, 0.33-0.80), and, prior to diagnosis, having more children to take care of (OR, 0.65; 95% CI, 0.54-0.79), being able to adjust working hours (OR, 0.55; 95% CI, 0.36-0.83) and not desiring to work less hours if that were to be financially feasible (OR, 1.8; 95% CI, 1.0-3.2).
CONCLUSIONS: Predominantly, work-related factors are associated with adverse work outcomes 5-10 years after diagnosis, whereas clinical factors are not. Our results need validation in prospective cohort studies, after which supportive interventions could be developed. IMPLICATIONS FOR CANCER SURVIVORS: Work-related factors should be considered in future interventions to prevent adverse work outcome 5-10 years after diagnosis.

Entities:  

Keywords:  Breast cancer; Cancer survivorship; Employment; Work

Mesh:

Year:  2019        PMID: 30637577     DOI: 10.1007/s11764-018-0731-7

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.442


  6 in total

1.  Long-Term Employment Outcomes among Female Cancer Survivors.

Authors:  Christine C Ekenga; Eunsun Kwon; BoRin Kim; Sojung Park
Journal:  Int J Environ Res Public Health       Date:  2020-04-16       Impact factor: 3.390

2.  Profiles of instrumental, emotional, and informational support in Chinese breast cancer patients undergoing chemotherapy: a latent class analysis.

Authors:  Tingting Cai; Qingmei Huang; Changrong Yuan
Journal:  BMC Womens Health       Date:  2021-04-29       Impact factor: 2.809

Review 3.  Breast Cancer Survivorship: the Role of Rehabilitation According to the International Classification of Functioning Disability and Health-a Scoping Review.

Authors:  Monica Pinto; Dario Calafiore; Maria Carmela Piccirillo; Massimo Costa; Ozden Ozyemisci Taskiran; Alessandro de Sire
Journal:  Curr Oncol Rep       Date:  2022-04-11       Impact factor: 5.945

4.  A randomised feasibility trial of an employer-based intervention for enhancing successful return to work of cancer survivors (MiLES intervention).

Authors:  M A Greidanus; A E de Rijk; A G E M de Boer; M E M M Bos; P W Plaisier; R M Smeenk; M H W Frings-Dresen; S J Tamminga
Journal:  BMC Public Health       Date:  2021-07-21       Impact factor: 3.295

5.  Introduction to special section on: current topics in cancer survivorship and work.

Authors:  A G E M de Boer; M A Greidanus; C S Dewa; S F A Duijts; S J Tamminga
Journal:  J Cancer Surviv       Date:  2020-03-23       Impact factor: 4.442

6.  Impact of Breast Cancer Treatment on Employment: Results of a Multicenter Prospective Cohort Study (CANTO).

Authors:  Agnes Dumas; Ines Vaz Luis; Thomas Bovagnet; Mayssam El Mouhebb; Antonio Di Meglio; Sandrine Pinto; Cecile Charles; Sarah Dauchy; Suzette Delaloge; Patrick Arveux; Charles Coutant; Paul Cottu; Anne Lesur; Florence Lerebours; Olivier Tredan; Laurence Vanlemmens; Christelle Levy; Jerome Lemonnier; Christelle Mesleard; Fabrice Andre; Gwenn Menvielle
Journal:  J Clin Oncol       Date:  2019-12-13       Impact factor: 44.544

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.